| Name | Title | Contact Details |
|---|
Founded in 2003, Benaissance has grown into a leader in Software as a Service solutions for COBRA and non COBRA administrators across the nation.
Communication Arts Associates is a Richmond, VA-based company in the Business Services sector.
Partnering with physician practices to deliver integrated behavioral health services and utilize Medicares New Collaborative Care (CoCM) program
gage continuing education is a Palm Harbor, FL-based company in the Business Services sector.
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.